POU6F1 is the transcription factor that might be involved in cell proliferation of clear cell adenocarcinoma of the ovary

Human Cell

Volumn 22, Issue 4, 2009, Pages 94-100

  Yoshioka, Norihito ^a   Suzuki, Nao ^a   Uekawa, Atsushi ^a   Kiguchi, Kazushige ^a   Ishizuka, Bunpei ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Caveolin 1; Cell proliferation; Clear cell adenocarcinoma of the ovary; POU6F1

Indexed keywords

CAVEOLIN 1; COMPLEMENTARY DNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR POU6F1; UNCLASSIFIED DRUG;

ARTICLE; CELL INFILTRATION; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CLEAR CELL CARCINOMA; DNA MICROARRAY; FEMALE; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MOLECULAR THERAPY; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

ADENOCARCINOMA, CLEAR CELL; CAVEOLIN 1; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; POU DOMAIN FACTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 70350475537     PISSN: 09147470     EISSN: 17490774     Source Type: Journal    
DOI: 10.1111/j.1749-0774.2009.00074.x     Document Type: Article

References (12)

1. Buchsbaum HJ, Brady MF, Delgado G et al. Surgical staging of carcinoma of the ovaries. Surg Gynecol Obstet 1989 169 : 226 232.
2. Silverberg SG. Histopathologic grading of ovarian carcinoma, a review and proposal. Int J Gynecol Pathol 2000 19 : 7 15.
3. Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. In : Rosai J, ed. Atlas of Tumor Pathology, 3rd Series. Fascicle 23. Washington, DC : Armed Forces Institute of Pathology, 1999 27 50.
4. Enomoto T, Kuragaki C, Yamasaki M et al. Is clear cell carcinoma and mucinous carcinoma of the ovary sensitive to combination chemotherapy with paclitaxel and carboplatin? Proc Am Soc Clin Oncol 2003 22 : 447.
5. Takano M, Sugiyama T, Yaegashi N et al. Progression-free survival and overall survival of patients with clear cell adenocarcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis. Int J Clin Oncol 2007 12 : 256 260.
6. Suzuki N, Higashiguchi A, Hasegawa Y et al. Loss of integrin α3 expression is associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cells. Hum Cell 2005 18 : 147 155.
7. Miotti S, Tomassetti A, Facetti I, Sanna E, Berno V, Canevari S. Simultaneous expression of Caveolin-1 and E-cadherin in ovarian Ca cells stabilizes adherens junctions through inhibition of src-related kinases. Am J Pathol 2005 167 : 1411 1427.
8. Sanna E, Miotti S, Mazzi M, De Santis G, Canevari S, Tomassetti A. Binding of nuclear caveolin-1 to promoter elements of growth-associated genes in ovarian carcinoma cells. Exp Cell Res 2007 313 : 1307 1317.
9. Burgermeister E, Liscovitch M, Rocken C, Schmid RM, Ebert MP. Caveats of caveolin-1 in cancer progression. Cancer Lett 2008 268 : 187 201.
10. Cordes N, Frick S, Brunner TB et al. Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1. Oncogene 2007 26 : 6851 6862.
11. Wey E, Schäfer BW. Identification of novel DNA binding sites recognized by the transcription factor mPOU (POU6F1). Biochem Biophys Res Commun 1996 220 : 271 279.
12. Okamoto K, Wakayama M, Noji S et al. A novel class of murine POU gene predominantly expressed in central nervous system. J Biol Chem 1993 268 : 7449 7457.